Nexium capsules RE Maintenance Specific Clinical Experience Investigation
Study identifier:D961HC00013
ClinicalTrials.gov identifier:NCT01562639
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Nexium capsules Specific Clinical Experience Investigation for Maintenance Therapy for Repeatedly Recurring/Relapsing Reflux Oesophagitis
Medical condition
repeatedly recurring esophagitis
Phase
N/A
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
647
Study type
Observational
Age
N/A
Date
Study Start Date: 01 Apr 2012
Primary Completion Date: 01 Jul 2014
Study Completion Date: 01 Jul 2014
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Sept 2016 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Nexium | - |
Contacts
Investigators
Principal Investigator
Shigeru Yoshida
Astrazeneca K.K.
